C284-0107 Screening compound: ethyl 4-{2-[(4-carbamoylpiperidin-1-yl)methyl]-6-nitro-4-oxo-3,4-dihydroquinazolin-3-yl}benzoate

C284-0107 Screening compound: ethyl 4-{2-[(4-carbamoylpiperidin-1-yl)methyl]-6-nitro-4-oxo-3,4-dihydroquinazolin-3-yl}benzoate
C284-0107 Screening compound: ethyl 4-{2-[(4-carbamoylpiperidin-1-yl)methyl]-6-nitro-4-oxo-3,4-dihydroquinazolin-3-yl}benzoate alternative view

Chemical Structure Depiction of ChemDiv screening compound C284-0107
ethyl 4-{2-[(4-carbamoylpiperidin-1-yl)methyl]-6-nitro-4-oxo-3,4-dihydroquinazolin-3-yl}benzoate

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C284-0107

Molecular Formula

C24H25N5O6 (C24 H25 N5 O6)

Compound Name

ethyl 4-{2-[(4-carbamoylpiperidin-1-yl)methyl]-6-nitro-4-oxo-3,4-dihydroquinazolin-3-yl}benzoate

IUPAC name

ethyl 4-{2-[(4-carbamoylpiperidin-1-yl)methyl]-6-nitro-4-oxo-34-dihydroquinazolin-3-yl}benzoate

SMILES

CCOC(c(cc1)ccc1N(C(CN(CC1)CCC1C(N)=O)=Nc(cc1)c2cc1[N+]([O-])=O)C2=O)=O

InChI

InChI=1S/C24H25N5O6/c1-2-35-24(32)16-3-5-17(6-4-16)28-21(14-27-11-9-15(10-12-27)22(25)30)26-20-8-7-18(29(33)34)13-19(20)23(28)31/h3-8,13,15H,2,9-12,14H2,1H3,(H2,25,30)

InChI Key

ZAQPJACUOYWUOO-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14740709

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

479.49

Hydrogen Bond Acceptors Count

13.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

11

Partition Coefficient, logP

1.531

Distribution Coefficient, logD

1.528

Water Solubility, LogSw

-2.44

Polar Surface Area

116.792

Acid Dissociation Constant (pKa)

14.92

Base Dissociation Constant (pKb)

5.14

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

33.30

C284-0107 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

Antiviral Annotated Library (21441 compounds)

Neurotransmitter Transporter Inhibitors Library (11024 compounds)

PI3K-Targeted Library (17255 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Nervous system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • GPCR
  • Ion Channels
  • Kinases

References: we are preparing a list of scientific research reports with C284-0107 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C284-0107?
Check Price and Availability of C284-0107, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C284-0107 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C284-0107
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C284-0107
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C284-0107 available by request